Diethylamine

Diethylamine

SCHEMBL16713992

CCNCC.COP(=O)(O)OC

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
SAT1 P21673 1/20 0.39
MMP1 P03956 4/20 0.37
MMP2 P08253 4/20 0.37
MMP3 P08254 3/20 0.37
MMP8 P22894 2/20 0.37
MMP9 P14780 2/20 0.37
PLA2G2A P14555 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
S1PR2 O95136 5/20 0.30
S1PR4 O95977 5/20 0.30
S1PR1 P21453 5/20 0.30
S1PR3 Q99500 5/20 0.30
ANPEP P15144 1/20 0.30
S1PR5 Q9H228 1/20 0.30
KDM4E B2RXH2 1/20 0.30
PPARD Q03181 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid Monomethyl Ester SCHEMBL16774559 0.86 TP53 (0.44) TP53SAT1MMP1MMP2MMP3
Propane SCHEMBL4629637 0.83 CA2 (0.35) MMP1MMP2MMP3MMP8PLA2G2A
Alcohol SCHEMBL7622017 0.80 PPARD (0.39) MMP1MMP2MMP3MMP8PLA2G2A
SCHEMBL16713982 0.80 ANPEP (0.45) SAT1MMP1MMP2MMP3MMP9
Diethylamine SCHEMBL29187214 0.80 TP53 (0.57) TP53SAT1MMP1MMP2MMP3
Diethylamine SCHEMBL320756 0.80 TP53 (0.57) TP53SAT1MMP1MMP2MMP3
Diethylamine SCHEMBL1203507 0.80 TP53 (0.57) TP53SAT1MMP1MMP2MMP3
Diethylamine SCHEMBL9484949 0.80 TP53 (0.57) TP53SAT1MMP1MMP2MMP3
SCHEMBL47754 0.80
SCHEMBL28223995 0.80 CA2 (0.43) MMP1MMP2MMP8MMP9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9472829-B2 Method for stabilizing LiPF6, electrolyte solution for nonaqueous secondary batteries having excellent thermal stability, and nonaqueous secondary battery having excellent thermal stability TOSOH F-TECH, INC. (JP) 2016-10-18 US disclosed
US-20150140445-A1 METHOD FOR STABILIZING LIPF6, ELECTROLYTE SOLUTION FOR NONAQUEOUS SECONDARY BATTERIES HAVING EXCELLENT THERMAL STABILITY, AND NONAQUEOUS SECONDARY BATTERY HAVING EXCELLENT THERMAL STABILITY TOSOH F-TECH, INC. (JP) 2015-05-21 US disclosed
CN-104364861-A Flame-retardant electrolytic capacitor NIPPON CHEMICON 2015-02-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150140445-A1 METHOD FOR STABILIZING LIPF6, ELECTROLYTE SOLUTION FOR NONAQUEOUS SECONDARY BATTERIES HAVING EXCELLENT THERMAL STABILITY, AND NONAQUEOUS SECONDARY BATTERY HAVING EXCELLENT THERMAL STABILITY ELOVL6, ABHD6, NAF1 TP53 1841/4885SAT1 585/4885MMP1 4804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.